Cécile Holweg

5.3k total citations · 1 hit paper
93 papers, 3.0k citations indexed

About

Cécile Holweg is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Cécile Holweg has authored 93 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Physiology, 36 papers in Pulmonary and Respiratory Medicine and 29 papers in Surgery. Recurrent topics in Cécile Holweg's work include Asthma and respiratory diseases (52 papers), Respiratory and Cough-Related Research (28 papers) and Transplantation: Methods and Outcomes (18 papers). Cécile Holweg is often cited by papers focused on Asthma and respiratory diseases (52 papers), Respiratory and Cough-Related Research (28 papers) and Transplantation: Methods and Outcomes (18 papers). Cécile Holweg collaborates with scholars based in United States, Netherlands and United Kingdom. Cécile Holweg's co-authors include Joseph R. Arron, John G. Matthews, Kenji Izuhara, Simon J. Conway, Carla C. Baan, Julie Olsson, Wendy S. Putnam, Aggie H.M.M. Balk, Nicola A. Hanania and Phillip E. Korenblat and has published in prestigious journals such as Circulation, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Cécile Holweg

89 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

2016 350 citations Nicola A. Hanania, Phillip E. Korenblat et al. The Lancet Respiratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cécile Holweg United States	27	1.4k	976	788	557	471	93	3.0k
J. W. Cohen Tervaert Netherlands	36	830 0.6×	2.6k 2.7×	1.3k 1.6×	306 0.5×	1.1k 2.4×	77	3.8k
Philippe Guilpain France	34	463 0.3×	1.4k 1.4×	814 1.0×	430 0.8×	885 1.9×	126	3.4k
Maria Grazia Sabbadini Italy	35	563 0.4×	642 0.7×	1.9k 2.5×	321 0.6×	1.1k 2.3×	87	3.5k
Noriharu Shijubo Japan	31	770 0.6×	1.5k 1.6×	528 0.7×	440 0.8×	308 0.7×	124	2.9k
Frank Moosig Germany	32	1.0k 0.8×	2.6k 2.6×	807 1.0×	518 0.9×	1.9k 4.1×	102	3.6k
M. Hamidou France	38	706 0.5×	1.3k 1.3×	1.2k 1.5×	484 0.9×	1.3k 2.8×	229	4.4k
Monique Hinchcliff United States	36	263 0.2×	953 1.0×	615 0.8×	536 1.0×	404 0.9×	97	3.5k
Achille Aouba France	30	694 0.5×	1.4k 1.4×	433 0.5×	373 0.7×	1.2k 2.6×	157	2.8k
Franco Franceschini Italy	37	604 0.4×	498 0.5×	1.3k 1.6×	437 0.8×	2.4k 5.0×	210	4.6k
Peter Lamprecht Germany	33	687 0.5×	2.1k 2.1×	1.2k 1.5×	284 0.5×	1.2k 2.6×	159	3.6k

Countries citing papers authored by Cécile Holweg

Since Specialization

Citations

This map shows the geographic impact of Cécile Holweg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Holweg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Holweg more than expected).

Fields of papers citing papers by Cécile Holweg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Holweg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Holweg. The network helps show where Cécile Holweg may publish in the future.

Co-authorship network of co-authors of Cécile Holweg

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Holweg. A scholar is included among the top collaborators of Cécile Holweg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Holweg. Cécile Holweg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holweg, Cécile, et al.. (2024). Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma. Respiratory Medicine. 223. 107537–107537. 2 indexed citations

Owczarczyk, Kasia, Matthew D. Cascino, Cécile Holweg, et al.. (2020). Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis. JCI Insight. 5(18). 9 indexed citations

Busby, John, Cécile Holweg, Akiko Chai, et al.. (2020). Using prednisolone and cortisol assays to assess adherence in oral corticosteroid dependant asthma: An analysis of test-retest repeatability. Pulmonary Pharmacology & Therapeutics. 64. 101951–101951. 2 indexed citations

Busby, John, Cécile Holweg, Akiko Chai, et al.. (2019). Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study. Thorax. 74(8). 806–809. 20 indexed citations

Ebmeier, Stefan, Alex Semprini, Rachel Varughese, et al.. (2018). Change in biomarkers of type-2 inflammation following severe exacerbations of asthma. Thorax. 74(1). 95–98. 16 indexed citations

Riley, John, Veit J. Erpenbeck, John G. Matthews, et al.. (2018). U-BIOPRED: evaluation of the value of a public–private partnership to industry. Drug Discovery Today. 23(9). 1622–1634. 11 indexed citations

Holweg, Cécile, John G. Matthews, Mark Holliday, et al.. (2017). Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthma. Allergy Asthma and Clinical Immunology. 13(1). 8–8. 10 indexed citations

Izuhara, Kenji, Simon J. Conway, Bethany B. Moore, et al.. (2016). Roles of Periostin in Respiratory Disorders. PMC. 2 indexed citations

Izuhara, Kenji, Simon J. Conway, Bethany B. Moore, et al.. (2016). Roles of Periostin in Respiratory Disorders. American Journal of Respiratory and Critical Care Medicine. 193(9). 949–956. 143 indexed citations

10.

Fingleton, James, Irene Braithwaite, Justin Travers, et al.. (2016). Serum periostin in obstructive airways disease. European Respiratory Journal. 47(5). 1383–1391. 39 indexed citations

11.

Hanania, Nicola A., Phillip E. Korenblat, Kenneth R. Chapman, et al.. (2016). Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. The Lancet Respiratory Medicine. 4(10). 781–796. 350 indexed citations breakdown →

12.

Simpson, Jodie L., Ian A. Yang, John W. Upham, et al.. (2015). Sputum and serum periostin levels are associated with, but do not predict sputum eosinophil proportion in severe asthma. American Journal of Respiratory and Critical Care Medicine. 191. 2 indexed citations

13.

Dennis, Glynn, Cécile Holweg, Sarah Kummerfeld, et al.. (2014). Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Research & Therapy. 16(2). R90–R90. 265 indexed citations

14.

Fingleton, James, Justin Travers, Robert Siebers, et al.. (2014). Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid. European Respiratory Journal. 44(Suppl 58). P3873–P3873. 3 indexed citations

15.

Lal, Preeti, Zheng Su, Cécile Holweg, et al.. (2011). Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment. Arthritis & Rheumatism. 63(12). 3681–3691. 54 indexed citations

16.

Potena, Luciano, William F. Fearon, Karsten Sydow, et al.. (2008). Asymmetric Dimethylarginine and Cardiac Allograft Vasculopathy Progression. Transplantation. 85(6). 827–833. 16 indexed citations

17.

Holweg, Cécile, A.M.A. Peeters, Aggie H.M.M. Balk, et al.. (2002). Effect of HLA-DR matching on acute rejection after clinical heart transplantation might be influenced by an IL-2 gene polymorphism. Transplantation. 73(8). 1353–1356. 11 indexed citations

18.

Holweg, Cécile, Carla C. Baan, Hubert G.M. Niesters, et al.. (2001). TGF-β1 Gene polymorphisms in patients with end-stage heart failure. The Journal of Heart and Lung Transplantation. 20(9). 979–984. 44 indexed citations

19.

Baan, Carla C., Cécile Holweg, Teun van Gelder, et al.. (1999). The macrophage-derived T-Cell growth factor interleukin-15 is present in interleukin-2–independent rejection after clinical heart and liver transplantation. Transplantation Proceedings. 31(7). 2726–2728. 8 indexed citations

20.

Baan, Carla C., Cécile Holweg, Hubert G.M. Niesters, et al.. (1999). ANTI-CD25 THERAPY REVEALS THE REDUNDANCY OF THE INTRAGRAFT CYTOKINE NETWORK AFTER CLINICAL HEART TRANSPLANTATION1. Transplantation. 67(6). 870–876. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact